Table 1.
Participant characteristics (n = 110)
| Characteristic | Participants |
|---|---|
| Years since medical school, No. (%) | |
| 0–10 | 4 (3.6) |
| 11–20 | 43 (39.1) |
| 21–30 | 43 (39.1) |
| > 30 | 15 (13.6) |
| Not completed | 5 (4.6) |
| Physicians caring for cancer patients, % | |
| Oncologist | 58 (52.7) |
| Non-oncologist (haematologist, pulmonologists, surgeons etc.) | 51 (46.7) |
| No. of unique patients per annum (based on monthly estimates) | |
| All physicians (Mean) | 1196.4 |
| Oncologists (Mean) | 1041.0 |
| Availability/Accessibility of molecularly indicated agents,%a | |
| Mean | 39.13 |
| Extent to which tumour pathology informs treatment choices as compared to tumour molecular profile, cmb | |
| Mean | 4.06 |
| Median | 3.60 |
| Low levels of confidence relating to somatic genomic results, No. (%) | |
| Interpreting | 56 (50.9) |
| Explaining | 44 (40.0) |
| Making treatment recommendations | 52 (47.3) |
| Mean | 50.7 (46.1) |
| Low levels of confidence in identifying consultants | |
| No. (%) | 31 (28.2) |
a Due to a printing error, responses could be analysed in only 67 cases
b Measured on a 10 cm line, with tumour pathology on the left and tumour molecular profile on the right